TP53 and cancer: The expression of mevalonate pathway‐related genes can be promoted in cancer cells via the stimulation of the phosphatidyl inositol 3‐kinase α (PI3K)–AKT–mammalian target of rapamycin complex 1 (mTORC1) pathway, TP53 and TP53 mutants, retinoblastoma, MYC, and E2F family proteins [3, 4].